suMMARY Propranolol and nadolol were used in two groups of patients having ventricular arrhythmias. The two groups were characterised by differences in sympathetic drive. The 10 nonadrenergic patients had idiopathic, monomorphic extrasystoles (isolated with fixed coupling or in pairs or salvoes) arising from the right ventricle or the septum. These extrasystoles were chronic and benign, with a slightly increased daytime frequency (day:night = 1.6). They disappeared on exercise. The nine adrenergic patients had less frequent but more complex polymorphic ventricular extrasystoles, and rapid and irregular tachycardias which were resistant. They occurred predominantly during the day and were associated particularly with stress and exercise. They were either idiopathic, or coexisted with mitral valve prolapse (three cases) or hypertrophic subaortic stenosis (one case) in young patients (mean age, 32 years) who did not have coronary heart disease. Nadolol was more effective than propranolol in controlling the arrhythmia, heart rate, and variations in sinus rhythm in the adrenergic group, while the arrhythmia was not controlled in the non-adrenergic group. Using clinical variables, comparison of the frequency of extrasystoles by day and night, and assessment of the antiarrhythmic effect of beta-blockers, the role of the sympathetic tone in nonischaemic ventricular arrhythmias may be elucidated. 
The role of the sympathetic nervous system in ventricular arrhythmias has been shown experimentallyl-3 and suggested by clinical observations.4-6 It has been difficult to determine which clinical variables most effectively demonstrate the significance of its influence, and hence the value of treatment by betablockade. This (Table) The 19 patients in this study had ventricular arrhythmias in the absence of coronary heart disease or previous myocardial infarction, and there was no cardiac, respiratory, or gastrointestinal contraindication to beta-blockade. They were allocated to one of the two groups on the basis of their tolerance of the Accepted for publication 21 September 1981 arrhythmia and the precipitating factors. Patients who could indulge in simple activities without palpitation were assumed to be insensitive to catecholamines and allocated to the non-adrenergic group. Patients complaining of palpitation that occurred exclusively in association with effort or that was aggravated by emotion were classified as adrenergic.
The non-adrenergic' group comprised six male and four female patients, with a mean age of 41 (range = 10 to 67). The arrhythmia was discovered either at routine examination (cases 1 to 6) or as a result of investigating "skipping of heart beat" at rest. Cardiovascular examination included electrocardiogram and echocardiogram, clinical, and radiological examination. The normal physical activity of these patients was undisturbed by their idiopathic ventricular extrasystoles. The four male and five female patients of the adrenergic group had a mean age of 32 (range = 12 to 55), and suffered far more striking arrhythmias.
Cases 11 to 13 were children with syncope of effort resulting from rapid and irregular ventricular tachycardia. They have been reported.7 Two young women (cases 14 and 15) had similar histories, but The mean heart rate was evaluated at 10 minute and hourly intervals. The overall cardiac rate was considered to be of sinus origin when the ventricular extrasystoles were isolated and followed by a compensatory pause. Frequent coupled beats, salvoes, sustained or frequent ventricular tachycardia result in apparently raised rates, but in these instances the ventricular rate does not reflect the sinus rate. In computing the minimum and maxnmum rates, by measurement of the fastest and slowest rates of a sliding 16 beat RR interval, these errors were eliminated by careful selection of the tracings used. The gradient "delta" of the sinus rate is determined by the difference between minimum and mimum rates over the 24 hour period and reflects the spontaneous variability of the sinus rate of ambulatory patients.
TREATMENT WITH BETA-BLOCKERS Each patient underwent treatment with two betablockers, the order of which was randomised. Dosage of the drug was determined by weight and severity of the rhythm disturbance. In 17 patients, propranolol was used as the baseline medication, while acebutolol was used for two patients. Acebutolol, 200 
Results
Indices including electrocardiograms, exercise tests, and ambulatory recordings were studied for the control and subsequent treatment periods. The two groups could not be differentiated on the basis of age (p = 0-25), sex (p = 0.29), or drug dosage (p = 0-80).
BASELINE CHARACTERISTICS OF VENTRICULAR ARRHYTHMIAS
(1) Origin and distribution of the arrhythnias (Table) The QRS morphology is clearly different in the two groups of patients. In the non-adrenergic group, the origin of the ventricular extrasystoles is the right ventricle in six patients (one apical, four septal) and the left ventricle in four patients (two septal). All the complexes of ventricular origin are monomorphic ( Fig. 1 clearly different phenomena in the two groups, but testing. In the nondid not establish the mechanisms of the arrhythmias. number of ventricu In four patients (cases 9, 10, 18, and 19), attempts at acceleration of the s initiating or terminating ventricular tachycardia by ever, it increased t pairs or repetitive stimuli did not give reliably repro-salvoes while reduci ducible results. The behaviour of the ventricular in the adrenergic gr extrasystoles as a function of the atrial stimulation rate isoprenaline, their was variable. In the non-adrenergic group, five aggravated, with sa patients (cases 3, 5, 6, 9, 10) had extrasystoles which and poorly toleratec were dependent on the atrial rate through a range of frequencies with minimum and maximum threshold (3) Exercise testing values. This was not true of case 1 with parasystole. In six cases of the nc Bi-, tri-, and quadrigeminy were seen to appear and lar extrasystoles disE disappear in relation to the atrial rate and occurred threshold value of t] mostly with fixed coupling. These characteristics were cases did the rate of disclosed on ambulatory monitoring in the remaining without complete ( patients who were not explored. In the adrenergic cases, the relative ra group, the incidence of ventricular extrasystoles was not modified by th hardly influenced by the atrial stimulation rate. They increase in the a disappeared only by overdriving the ventricles and extrasystoles per mi their frequency only increased on exercise testing, but rate. not with acceleration of the pacing rate. The
All patients in T-i~~~~~-141 small doses of isoprenaline gave with those obtained on exercise -adrenergic group, it reduced the alar extrasystoles precipitated by ,inus rate. In cases 9 and 10, howthe duration and the rate of the ing their incidence. Of the patients roup who were explored and given ventricular arrhythmias were alvoes which were longer, faster, d.
g (Table) on-adrenergic group, the ventricuappeared with effort on reaching a he sinus rate (Fig. 3) exercise testing with the exception of case 19 in whom exercise induced a poorly tolerated ventricular tachycardia (Fig. 4) . In the remaining eight, exercise induced ventricular tachycardia in four, caused an increased frequency of short runs of ventricular tachycardia in three, and caused an absolute and relative increase in the frequency of ventricular extrasystoles in one.
(4) Ambulatoiy electrocardiographic monitoring ( The cardiac rate over 24 hours was 78-5 ± 9 3 and was greater by day (87.0 ± 10.5) than by night (64.4 ± 8-4) (p<0-01) with a ratio of 1.35. Delta over 24 hours was 76 ± 10 with an average maximum of 130/min and average minimum of 54/min.
There were significant differences between the two groups for the day:night ratios of rates of ventricular extrasystoles, 1-6 to 3 (p<0-05) and heart rates, 1-26 to 1-35 (p<0.05). There was a difference in the delta values (p<0-05). (Table, Fig. 6 and 7) .
EFFECTS OF TREATMENT WITH BETA-BLOCKERS
(1) Effects of propranolol In the non-adrenergic group, propranolol (and acebutolol when it was used) does not modify the incidence of ventricular extrasystoles found on exercise testing (p=0.37) (Table) . There is a decrease of 23% in the rate of ventricular extrasystoles in 24 hours, but this was not found to be statistically significant. Neither the average heart rate in 24 hours (-8%) nor the delta value (-11%) was significantly altered (Fig. 7) (Fig. 6) ..:
90 -* X Fig. 6 Comparison ofthe hourly ventricular extrasystolic rate between the non-adrenergic group and the adrenergic,for both day and night and duning control and therapeutic periods. Left, the non-adrenergic patients (solid circles). The left-hand column represents daytime, from 10 am to 6 pm, and the right, night time, from I am to S am. There is no signg'icant difference between the groups. Right, the adrenergic patients (solid stars). Left-hand colunm again shows daytime results, conversely the right-hand column. The daytime ventricular extrasystolic rate is sigBficantly lowered by beta-blockade, especially by nadolol. At night, the effect is not sig'iicant with propranolol, but is sign'icant with nadolol.
some indices were applicable to either group as a arrhythmia emerge from the cases studied. Thus whole, there were discrepancies when applied to cer-assessment of the mechanism of the arrhythmias is tain individual cases. For example, cases 9 and 10 of facilitated and therapeutic consequences are disthe non-adrenergic group shared characteristics with closed. patients of the adrenergic group. riods. The mean cardiac rate over
The arrhythmias were polymorphic, of left venve. The control values (mean + SE) tricular origin, and with a variable but often short he two groups and both are coupling interval. There were short, rapid, and by nadolol. Propranolol causes a irregular salvoes, the rate of which often exceeded n the adrenergic patients only. Delta 200/min. Exercise tests were limited by the symptoms itine examinaton. Some of these arrhythmias, in contrast to both infusion of isoof a sensation of the heart skip-prenaline and exertion. The sensitivity to the isong at rest and disappearing on prenaline, but not the dosage, differentiates the two no organic heart disease in this groups studied. group. The ventricular extrasystoles were mostly monomorphic, being of right ventricular or septal origin, with a relatively long coupling interval which varied within narrow limits (400 to 600 ms). Bi-, tri-, and quadrigeminy was frequently observed and the occurrence ofarrhythmias was dependent on the sinus rate'3 14 between two thresholds. Usually the lower one was apparent at rest, or at night, from 24 hour electrocardiograms. More (Fig. 5) .
THERAPEUTIC EFFECT OF BETA-BLOCKADE Two drugs were used, of which propranolol served as a reference and nadolol as the more powerful agent. This represents a further approach to the problem of the mechanism of arrhythmias. The role of other drugs as membrane stabilisers is not discussed in this article. The two groups respond in opposite ways to quinidine and quinidine-like agents, however, the non-adrenergic patients being sensitive and the adrenergic patients being resistant. The converse was true for beta-blockers.
The arrhythmias were not suppressed in the nonadrenergic group by propranolol or nadolol, though they may have been influenced. Fig. 6 clearly shows that the rate of ventricular extrasystoles may rise, fall, or remain the same with either drug by day or by night. These changes were mainly related to the sinus rate, the arrhythmias featuring in the range of sinus rates between upper and lower threshold values. Thus the arrhythmias may have been more or less manifest on this basis. In the adrenergic group, however, there was always improvement with beta-blockade. Complete control of the arrhythmias was not necessarily achieved though the arrhythmias were heavily dependent on sympathetic drive, and some patients improved further on addition of quinidine. Detailed examination of the results showed that in the nonadrenergic group, the rate was unchanged by nadolol (-6%) but diminished by 23% by propranolol. This is not statistically significant, but raises the question of the quinidine-like effect of propranolol which has been proven experimentally yet is not supported by clinical evidence.
In the adrenergic group, nadolol is effective by day and night,. whereas propranolol was effective only by day. This suggests that the dependence of the arrhythmias on the sympathetic drive is more obvious by day, so that the less powerful agent (propranolol) has a more visible effect during the day. Propranolol and nadolol have different effects on the cardiac rate and the delta value. These are unaffected by propranolol in the non-adrenergic group, but quite significantly altered in the adrenergic group. Nadolol, on the other hand, modifies these indices in both groups, though to a greater extent in the adrenergic group. While there is a difference in the control values for delta between the two groups, no such difference exists for cardiac rate or delta while nadolol was administered.
These quantifiable results correlate with the symptomatic improvement described by the patients, which was greater with nadolol than with propranolol. Currently, six patients (cases 11 to 13, 15, 18, 19) are controlled on long term nadolol therapy, having been incompletely controlled by propranolol alone. It may be argued that propranolol appears less effective, but that this is attributable to using the same doses for both nadolol and propranolol. If, however, the dose of the latter is doubled, only modest therapeutic gain is achieved. No such gain was noted when the dose of nadolol was doubled.
In conclusion, there appears to be correlation between ventricular extrasystoles, cardiac rate, and the maximum variations in sinus rate on the one hand, and clinical symptoms and electrocardiographic findings both at rest and on exercise.'7 The behaviour of the arrhythmias observed under the influence of beta-blockade confirms that there is an important contribution from the sympathetic nervous system in certain ventricular arrhythmias. Conversely, the absence of antiarrhythmic effect noted in other cases treated with beta-blockers sheds light on the mechanism of these. It is also of value in establishing the indication for using various drugs. The cases intermediate between the extremes of the range studied may represent a mixed picture where an arrhythmia is influenced by, but is not completely dependent on, sympathetic drive, providing an indication for combined therapies. 
